Aier Eye Hospital Group
8
33M
6
0.40
2
0.25
2
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Changsha. The fund was located in Asia if to be more exact in China.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Aier Eye Hospital Group, startups are often financed by Trustbridge Partners, Sequoia Capital China, Redpoint.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Qihoo 360 Technology. Among the most popular fund investment industries, there are Mobile, Internet. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The high activity for fund was in 2016. The increased amount of exits for fund were in 2011. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
The overall number of key employees were 2.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.40
- Follow on index
- 0.25
- Investments by industry
- Software (3)
- Education (2)
- Information Technology (2)
- Biotechnology (2)
- Health Diagnostics (2) Show 11 more
- Investments by region
-
- China (8)
- Peak activity year
- 2016
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 3B
- Group Appearance index
- 0.50
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Svision | 09 Mar 2023 | Health Care, Health Diagnostics, Medical Device | Late Stage Venture | 46M | Guangdong Province, Huizhou, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.